Elevated acetoacetate and monocyte chemotactic protein-1 levels in cord blood of infants of diabetic mothers

Neonatology

Volumn 102, Issue 3, 2012, Pages 163-168

  Kurepa, Dalibor ^a   Pramanik, Arun K ^a   Kakkilaya, Venkatakrishna ^a   Caldito, Gloria ^a   Groome, Lynn J ^a   Bocchini, Joseph A ^a   Jain, Sushil K ^a  

^a LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

Acetoacetate; Hyperketonemia; Infant of diabetic mother; Monocyte chemotactic protein 1; Oxidative stress

Indexed keywords

ACETOACETIC ACID; MONOCYTE CHEMOTACTIC PROTEIN 1;

ADULT; ARTICLE; BLOOD SAMPLING; CELL CULTURE; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; INFLAMMATION; MONOCYTE; OXIDATION; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN SECRETION; UMBILICAL CORD BLOOD;

ACETOACETATES; ADULT; CASE-CONTROL STUDIES; CHEMOKINE CCL2; DIABETES MELLITUS, TYPE 1; DIABETES, GESTATIONAL; FEMALE; FETAL BLOOD; HUMANS; INFANT, NEWBORN; PREGNANCY; PREGNANCY IN DIABETICS; PRENATAL EXPOSURE DELAYED EFFECTS; U937 CELLS; UP-REGULATION; YOUNG ADULT;

EID: 84863511599     PISSN: 16617800     EISSN: 16617819     Source Type: Journal    
DOI: 10.1159/000339286     Document Type: Article

References (27)

1. Yogev Y, Visser GH: Obesity, gestational diabetes and pregnancy outcome. Semin Fetal Neonatal Med 2009; 14: 77-84.
2. Agoudemos M, Reinking BE, Koppenhafer SL, Segar JL, Scholz TD: Programming of adult cardiovascular disease following exposure to late-gestation hyperglycemia. Neonatology 2011; 100: 198-205.
3. Koskinen A, Laiho A, Lukkarinen H, Kaapa P: Maternal hyperglycemia modifies extracellular matrix signaling pathways in neonatal rat lung. Neonatology 2010; 98: 387-396.
4. Newton CA, Raskin P: Diabetic ketoacidosis in type 1 and type 2 diabetes mellitus: clinical and biochemical differences. Arch Intern Med 2004; 164: 1925-1931.
5. Jain SK, Kannan K, Lim G, Matthews-Greer J, McVie R, Bocchini JA Jr: Elevated blood interleukin-6 levels in hyperketonemic type diabetic patients and secretion by acetoacetate- treated cultured U937 monocytes. Diabetes Care 2003; 26: 2139-2143
6. Jain SK, Kannan K, Lim G, McVie R, Bocchini JA Jr: Hyperketonemia increases tumor necrosis factor-alpha secretion in cultured U937 monocytes and type 1 diabetic patients and is apparently mediated by oxidative stress and cAMP deficiency. Diabetes 2002; 51: 2287-2293.
7. Rains JL, Jain SK: Hyperketonemia increases monocyte adhesion to endothelial cells and is mediated by LFA-1 expression in monocytes and ICAM 1 expression in endothelial cells. Am J Physiol Endocrinol Metab 2011; 301:E298-E306.
8. Thornton NL, Cody MJ, Yost CC: Toll-like receptor 1/2 stimulation induces elevated interleukin-secretion in polymorphonuclear leukocytes isolated from preterm and term newborn infants. Neonatology 2012; 101: 140-146.
9. Verbruggen SC, Landzaat LJ, Reiss IKM, van Goudoever JB, Joosten KFM: Efficacy and safety of a tight glucose control protocol in critically ill term neonates. Neonatology 2012; 101: 232-238.
10. Dahlgren J, Nilsson C, Jennische E, Ho HP, Eriksson E, Niklasson A, Bjorntorp P, Albertsson Wikland K, Holmang A: Prenatal cytokine exposure results in obesity and gender- specific programming. Am J Physiol Endocrinol Metab 2001; 281:E326-E334.
11. Rizzo T, Metzger BE, Burns WJ, Burns K: Correlations between antepartum maternal metabolism and child intelligence. N Engl J Med 1991; 26; 325: 911-916.
12. Clark KE, Miodovnik M, Skillman CA, Mimouni F: Review of fetal cardiovascular and metabolic responses to diabetic insults in the pregnant ewe. Am J Perinatol 1998; 5: 312-318.
13. Candiloros HMS, Zeghari N, Donner M, Drouin P, Ziegler O: Decreased erythrocyte membrane fluidity in poorly controlled IDDM. Influence of ketone bodies. Diabetes Care 1995; 18: 549-551.
14. Nelson SM, Sattar N, Freeman DJ, Walker JD, Lindsay R: Inflammation and endothelial activation is evident at birth in offspring of mothers with type 1 diabetes. Diabetes 2007; 56: 2697-2704.
15. Lindegaard ML, Svarrer EM, Damm P, Mathiesen ER, Nielsen LB: Increased LDL cholesterol and CRP in infants of mothers with type 1 diabetes. Diabetes Metab Res Rev 2008; 24: 465-471.
16. Yadav A, Saini V, Arora S: MCP-1: chemoattractant with a role beyond immunity: a review. Clin Chim Acta 2010; 411: 1570-1579.
17. Takahashi N, Uehara R, Kobayashi M, Yada Y, Koike Y, Kawamata R, Odaka J, Honma Y, Momoi MY: Cytokine profiles of seventeen cytokines, growth factors and chemokines in cord blood and its relation to perinatal clinical findings. Cytokine 2010; 49: 331-337.
18. Denison FC, Kelly RW, Calder AA, Riley SC: Cytokine secretion by human fetal membranes, decidua and placenta at term. Hum Reprod 1998; 13: 3560-3565.
19. Briana DD, Boutsikou M, Baka S, Papadopoulos G, Gourgiotis D et. al.: Perinatal plasma monocyte chemotactic protein-1 concentrations in intrauterine growth restriction. Mediators Inflamm 2007;2007:65032.
20. Piemonti L, Calori G, Mercalli A, Lattuada G, Monti P, Garancini MP, Costantino F, Ruotolo G, Luzi L, Perseghin G: Fasting plasma leptin, tumor necrosis factor-alpha receptor 2, and monocyte chemoattracting protein 1 concentration in a population of glucose-tolerant and glucose-intolerant women: impact on cardiovascular mortality. Diabetes Care 2003; 26: 2883-2889.
21. Nomura S, Shouzu A, Omoto S, Nishikawa M, Fukuhara S: Significance of chemokines and activated platelets in patients with diabetes. Clin Exp Immunol 2000; 121: 437-443.
22. Lappas M, Hiden U, Desoye G, Froehlich J, Hauguel-de Mouzon S, Jawerbaum A: The role of oxidative stress in the pathophysiology of gestational diabetes mellitus. Antioxid Redox Signal 2011; 15: 3061-3100.
23. Wender-Ozegowska E, Michalowska-Wender G, Zawiejska A, Pietryga M, Brazert J, Wender M: Concentration of chemokines in peripheral blood in first trimester of diabetic pregnancy. Acta Obstet Gynecol Scand 2008; 87: 14-19.
24. Kinalski M, Sledziewski A, Telejko B, Kowalska I, Kretowski A, Zarzycki W, Kinalska I: Lipid peroxidation, antioxidant defence and acid-base status in cord blood at birth: the influence of diabetes. Horm Metab Res 2001; 33: 227-231.
25. Rains JL, Jain SK: Oxidative stress, insulin signaling, and diabetes. Free Radic Biol Med 2011; 50: 567-575.
26. Jain SK, McVie R: Hyperketonemia can increase lipid peroxidation and lower glutathione levels in human erythrocytes in vitro and in type 1 diabetic patients. Diabetes 1999; 48: 1850-1855.
27. Jain SK, Kannan K, Lim G: Ketosis (acetoacetate) can generate oxygen radicals and cause increased lipid peroxidation and growth inhibition in human endothelial cells. Free Radic Biol Med 1998; 25: 1083-1088.